Company Overview and News


Add AFP
to your dashboard

Headline News

Edison Issues Outlook on AFT Pharmaceuticals (AFT)

2017-12-13 accesswire
LONDON, UK / ACCESSWIRE / December 13, 2017 / AFT Pharmaceuticals (NZSE: AFT) is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC products through its own salesforce in New Zealand, Australia and South-East Asia. It has been expanding its geographic footprint thanks mainly to Maxigesic, its paracetamol (acetaminophen)/ibuprofen combination product.

NZ shares fall, led by A2, Kathmandu; Ryman, Stride gain after results

2017-11-23 nzherald.co.nz
New Zealand shares fell, led by A2 Milk and Kathmandu Holdings while Ryman Healthcare and Stride Property Group gained following their results. (8-0)

A2 Milk, Kathmandu lead dip

2017-11-23 nzherald.co.nz
New Zealand shares fell, led by A2 Milk and Kathmandu Holdings, while Ryman Healthcare and Stride Property Group gained following their results. (8-0)

AFT loss narrows in half-year

2017-11-23 radionz.co.nz
The maker of the Maxigesic painkiller has narrowed its half-year loss because of improving revenue in Australia.

AFT Pharmaceuticals narrows first-half loss, on track for profitability

2017-11-22 nzherald.co.nz
AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, narrowed its first-half loss and said it is still on track to return to profitability this financial year or the next as it increases the number of markets where its products are sold.

AFT Pharmaceuticals reports FY17 loss but sees return to profit on the horizon

2017-05-23 nzherald.co.nz
AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, reported a full-year loss in the year to March 31 but expects to significantly narrow those deficits this year and return to profitability in the 2018/19 period.

AFT Pharmaceuticals raises $9.1m via redeemable share issue, announces SPP

2017-03-17 nzherald.co.nz
AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, raised new funds through a redeemable share issue to fuel international growth and announced plans to raise more capital in a share purchase plan.

Market lower as reporting season fails to spark activity

2017-02-17 nzherald.co.nz
New Zealand shares fell, led lower by Sky Network Television and Spark New Zealand, while Auckland International Airport gained after its first-half profit rose 19 per cent.

AFT Pharmaceuticals expects sales to hit analyst forecast of $70 million

2017-02-16 nzherald.co.nz
AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, expects annual sales to meet analysts' forecasts of about $70 million and has adjusted its loan covenant with shareholder Capital Royalty Group.

AFT Pharmaceuticals eyes higher sales after rescheduling of analgesics

2016-12-20 proactiveinvestors.com.au
The TGA has confirmed an interim decision that all medicines containing codeine be rescheduled to prescription-only medicines effective 1 February 2018. These products are being up-scheduled due to the risk of dependence and adverse events compared to safer analgesic products like Maxigesic. Maxigesic is a codeine-free analgesic that uses a patented combination of paracetamol and ibuprofen. AFT launched Maxigesic in Australia in 2014 and the brand is now becoming established with pharmacists and consumers.

Milford to close out new $150m private equity fund early

2016-12-20 nzherald.co.nz
Milford Asset Management will close out its recently launched private equity fund earlier than planned after finding more investor interest than expected.

NZ shares rise led by Tegel

2016-12-20 nzherald.co.nz
New Zealand shares rose as Tegel Group Holdings continued its rebound from last week's record low while Warehouse Group dropped after weaker earnings guidance.

AFT sees upside from restricted codeine sales

2016-12-20 nzherald.co.nz
New Zealand's AFT Pharmaceuticals expects to benefit from news that all medicines containing codeine will be prescription-only in Australia from February 1, 2018.

Index ends week on high note, rebounding from 5-day slide

2016-12-16 nzherald.co.nz
NZ shares rose, snapping five days of decline, with Tegel Group Holdings and A2 Milk Co recovering from being sold off earlier in the week, while Vista Group International and Infratil fell.

AFT to re-apply for heart medicine contract after shortages

2016-12-16 nzherald.co.nz
AFT Pharmaceuticals, the Auckland-based drug-maker, will have to re-apply to Pharmac for a heart medicine supply contract it won in July 2015 after suffering disrupted supply over the past year.